May 16, 2011
PSA Test Could Be Improved to Spot Prostate
CancerAmid the controversy swirling
around the value of PSA testing as a screen for prostate cancer,
new evidence emerges that there may be ways to fine-tune the
screening so it benefits more men, while avoiding unnecessary
biopsies and treatment.
New Drug Extends Life a Bit in Advanced Prostate
CancerFor men with advanced
hormone-resistant prostate cancer who have also failed
chemotherapy, the new drug Zytiga (abiraterone acetate) along with
the steroid prednisone appears to increase survival modestly, a new
study reports.
Victrelis Approved for Chronic Hepatitis CVictrelis (boceprevir) has
been approved by the U.S. Food and Drug Administration to treat
chronic hepatitis C, in tandem with the two additional drugs,
pegylated interferon alfa and ribavirin.